Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 30:18:100192.
doi: 10.1016/j.eurox.2023.100192. eCollection 2023 Jun.

Cannabis use preferences in women with myofascial pelvic pain: A cross-sectional study

Affiliations

Cannabis use preferences in women with myofascial pelvic pain: A cross-sectional study

Emily C Yang et al. Eur J Obstet Gynecol Reprod Biol X. .

Abstract

Objective: Myofascial tenderness is present in most chronic pelvic pain conditions and causes significant distress to patients. Treatment is challenging and often not curative. Cannabis is often used for self-management of chronic pelvic pain. However, we do not know which concentrations and routes of administration are most acceptable to users. We aimed to investigate patterns and willingness of cannabis product use among both habitual users and non-users with myofascial pelvic pain (MPP), to inform therapeutic development.

Study design: We conducted a cross-sectional study of questionnaire responses from female patients with MPP from two tertiary pelvic pain centers. We aimed for a convenience sample of 100 responses with representation from both centers. Inclusion criteria were age over 18 with pelvic floor muscle tenderness on standard gynecologic examination. We collected information on demographics, pelvic pain history, cannabis use status, cannabis use preferences, validated opioid misuse risk assessment, and interest in using gynecologic cannabis products and used descriptive analyses.

Results: 77/135 (57 %) questionnaire respondents were cannabis users and 58 (43 %) were non-users. Most users consume cannabis daily, (48.1 %) orally (66.2 %) or by smoking (60.7 %), and rated cannabis as effective at relieving pelvic pain. 37/58 (63.8 %) non-cannabis users responded that they would be willing to use cannabis for pelvic pain. Lack of information and potential adverse effects were the most common reasons for unwillingness to use. Approximately 3 of 4 respondents were willing to try vaginal or vulvar application of cannabis products for pelvic pain.

Conclusions: This cross-sectional study describes cannabis use patterns in MPP patients. Topical vulvar and vaginal cannabis products are of strong interest to both cannabis users and non-users and warrant further research.

Keywords: Cannabis; Chronic pelvic pain; Myofascial pelvic pain; Vaginal suppository; Vulvar cream.

PubMed Disclaimer

Conflict of interest statement

MG received the D.A. Boyes Memorial Research Award which partially funded this project. AB has received compensation related to his research through Emerald Health Therapeutics and Ascension Sciences. The other authors have no relevant conflicts of interest.

Figures

Fig. A
Fig. A
Recruitment and data collection flowchart.
Fig. B
Fig. B
Willingness to use gynecological cannabis products if available.

Similar articles

Cited by

References

    1. Mathias S.D., Kuppermann M., Liberman R.F., Lipschutz R.C., Steege J.F. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol. 1996;87(3):321–327. doi: 10.1016/0029-7844(95)00458-0. - DOI - PubMed
    1. Manz J., Hyakutake M., Kelly E. Calling for openness to the study of cannabis use in chronic pelvic pain. J Obstet Gynecol Can. 2020;43(5):611–613. - PubMed
    1. Ross V., Detterman C., Hallisey A. Myofascial pelvic pain: an overlooked and treatable cause of chronic pelvic pain. J Midwifery Women's Health. 2021;66(2):148–160. - PubMed
    1. Gyang A., Hartman M., Lamvu G. Musculoskeletal causes of chronic pelvic pain: what a gynecologist should know. Obstet Gynecol. 2013;121:645–650. - PubMed
    1. Bo K., Frawley H.C., Haylen B.T., et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Int Urogynecol J. 2017;28(2):191–213. - PubMed

LinkOut - more resources